Paradigm Biopharmaceuticals | PAR - Debt

Stock Price
0.29
Daily Change
-0.02 -4.92%
Monthly
-14.71%
Yearly
-42.00%
Q1 Forecast
0.30

Paradigm Biopharmaceuticals reported AUD181.4K in Debt for its fiscal semester ending in December of 2024.





Debt Change Date
Avita Medical AUD 44.59M 1.4M Jun/2025
Medical Developments International AUD 1.99M 152K Jun/2025
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Pacific Edge NZD 2.9M 425K Mar/2025
PYC Therapeutics AUD 1.02M 185.07K Jun/2025
Telix Pharmaceuticals AUD 581.45M 559.3M Dec/2024